ArticleCurrent infectious disease reports2010
Staphylococcal toxic shock syndrome: mechanisms and management.
Article in Current infectious disease reports, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 75 citations in OpenAlex.
- Article
- Myopathies in clinical care: a focus on treatable causes.Journal of neural transmission (Vienna, Austria : 1996) · 2026Review
- Analysis of the virulence potential, ability to form biofilms and susceptibility to bacteriocins ofJournal of veterinary research · 2026Article
- Characterization and diversity of methicillin-resistant Staphylococcus aureus in two hospitals in Gabon.BMC infectious diseases · 2025Article
- Identification of themBio · 2025Article
- Pathogenesis, Diagnosis, and Management of Cytokine Release Syndrome in Patients with Cancer: Focus on Infectious Disease Considerations.Current oncology (Toronto, Ont.) · 2025Review
- The pathogenicity and virulence of the opportunistic pathogenVirulence · 2024Review
- Genomic characterization of methicillin-resistant Staphylococcus aureus isolated from patients attending regional referral hospitals in Tanzania.BMC medical genomics · 2024Article
- Review
- Emerging infection: streptococcal toxic shock-like syndrome caused by group B Streptococcus (GBS),Autopsy & case reports · 2024Article
- Combining Genome Surveillance and Metadata To Characterize the Diversity of Staphylococcus aureus Circulating in an Italian Hospital over a 9-Year Period.Microbiology spectrum · 2023Article
- Bacterial toxins and heart function: heat-labileBiophysical reviews · 2023Article
- Vancomycin Resistance inMicroorganisms · 2022Review
- Fracture-related infection.Nature reviews. Disease primers · 2022Review
- Controlling skin microbiome as a new bacteriotherapy for inflammatory skin diseases.Inflammation and regeneration · 2022Review
- What Are the Immune Responses That Allow Us to Live With Incurable Bone Infection, and How Can They Be Augmented to Improve Outcomes After Prosthetic Joint Infection?Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022Article
- The role of pathogens in diabetes pathogenesis and the potential of immunoproteomics as a diagnostic and prognostic tool.Frontiers in microbiology · 2022Review
- A Structured Approach to Skin and Soft Tissue Infections (SSTIs) in an Ambulatory Setting.Clinics and practice · 2021Review
- Management of Infectious Emergencies for the Inpatient Dermatologist.Current dermatology reports · 2021Review
- Staphylococcal toxic shock syndrome in a lactating mother with breast abscess: A case report.Annals of medicine and surgery (2012) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Staphylococcal toxic shock syndrome is a rare complication of Staphylococcus aureus infection in which bacterial toxins act as superantigens, activating very large numbers of T cells and generating an overwhelming immune-mediated cytokine avalanche that manifests clinically as fever, rash, shock, and rapidly progressive multiple organ failure, often in young, previously healthy patients. The syndrome can occur with any site of S. aureus infection, and so clinicians of all medical specialties should have a firm grasp of the presentation and management. In this article, we review the literature on the pathophysiology, clinical features, and treatment of this serious condition with emphasis on recent insights into pathophysiology and on information of relevance to the practicing clinician.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.